Pegylated Interferon to Treat Chronic Hepatitis D

NCT00023322 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

13

Enrollment

NIH

Sponsor class

Conditions

Hepatitis D

Interventions

DRUG: Peginterferon Alpha-2a

Sponsor

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)